Enterprise Value

-51.52M

Cash

90.84M

Avg Qtr Burn

-17.48M

Short % of Float

2.65%

Insider Ownership

16.25%

Institutional Own.

67.75%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ALG-055009 (THR-β Agonist) Details
Non-alcoholic steatohepatitis

Phase 2a

Initiation

Phase 1/2

Update

Phase 1

Data readout

Failed

Discontinued

ALG-125755 Details
Chronic hepatitis B, Liver disease

Failed

Discontinued